牛牛AI助理已提取核心訊息
On February 27, 2024, Pfizer Inc. (PFE) reported that Executive Vice President Alexandre de Germay was granted 74,377 shares of common stock. The transaction, which was completed on the same day, was a grant and not a purchase, indicating the shares were awarded at no cost to de Germay. Following this transaction, de Germay's direct holdings in Pfizer common stock amounted to a total of 74,377 shares. The grant is part of the company's compensation structure for its executives and is a common practice in the industry to incentivize management performance.
On February 27, 2024, Pfizer Inc. (PFE) reported that Executive Vice President Alexandre de Germay was granted 74,377 shares of common stock. The transaction, which was completed on the same day, was a grant and not a purchase, indicating the shares were awarded at no cost to de Germay. Following this transaction, de Germay's direct holdings in Pfizer common stock amounted to a total of 74,377 shares. The grant is part of the company's compensation structure for its executives and is a common practice in the industry to incentivize management performance.
2024年2月27日，輝瑞公司（PFE）報告稱，執行副總裁亞歷山大·德傑爾梅獲得了74,377股普通股。該交易於當天完成，是贈款而不是收購，這表明股票是免費授予德傑爾梅的。在這筆交易之後，德傑直接持有的輝瑞普通股共計74,377股。該補助金是公司高管薪酬結構的一部分，也是業內激勵管理績效的常見做法。
2024年2月27日，輝瑞公司（PFE）報告稱，執行副總裁亞歷山大·德傑爾梅獲得了74,377股普通股。該交易於當天完成，是贈款而不是收購，這表明股票是免費授予德傑爾梅的。在這筆交易之後，德傑直接持有的輝瑞普通股共計74,377股。該補助金是公司高管薪酬結構的一部分，也是業內激勵管理績效的常見做法。
有用
沒用